Navigation Links
InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
Date:1/22/2009

The Company's groundbreaking products are featured in Genetic Engineering News for delivering the promise of safety without sacrificing productivity and performance.

Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria's product line was featured in the Jan. 15, 2009 edition of Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, entitled Culture Media Underlies Productivity Gains, referenced the productivity and safety improvements achieved through cell culture media optimization. New media components, such as InVitria's animal free recombinant media, have contributed to these improvements.

Test results have confirmed that InVitria's recombinant albumin (Cellastim™) outperforms plasma-derived human serum albumin and results in productivity improvements in CHO and hybridoma cell lines.

InVitria's recombinant lactoferrin (Lacromin™) is a strong cell growth factor and is capable of performing better in cell culture media than insulin and insulin-like growth factors. Research has shown Lacromin™ to be a major advance in promoting cell growth and productivity across a variety of cell lines.

Also mentioned in the article is InVitria's Lysobac™, a cell lysis reagent used in microbial fermentation to improve recombinant protein yield and deliver consistent quality, as well as the safety of an animal free reagent. Lysobac™ is many times more active than chicken lysozyme.

InVitria's performance enhancing recombinants offer producers affordable, well-defined and regulatory compliant cell culture media and bacterial lysis components. They can also contribute to operational efficiency and reduced capital costs.

"InVitria is committed to improving our customers' cell culture and bacterial fermentation performance by producing safe, consistent and affordable components," said Scott Deeter, President of InVitria. "We have been greatly encouraged by the results InVitria customers have achieved using our products. We hope to build upon these successes and share with the bioprocessing, diagnostic and stem cell and regenerative medicine communities the power of InVitria's products."

About InVitria
InVitria manufactures and sells animal free components for cell culture media and bacterial lysis. InVitria's affordable products can enhance cell growth, reduce doubling times and optimize performance for the bioprocessing, stem cell and regenerative medicine, life science and diagnostics markets.

Learn more about InVitria's products at InVitria

Contact InVitria's product customer service specialists by e-mail or phone.

Phone: 1-800-916-8311

# # #

Read the full story at http://www.prweb.com/releases/genengnews/invitria/prweb1898894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
2. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
3. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
4. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
5. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
6. InVitria Expands Sales Team
7. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
8. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
9. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
10. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
11. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
Breaking Biology News(10 mins):